see c correa protecting test data for pharmaceutical and agrochemical products under free trade agreements in negotiating health pp as mentioned before however it is widely recognized that this obligation creates insurmountable barriers for generic producers in terms of financial resources and time where the protected data concern offpatent substances a data exclusivity regime therefore erects an important new market access barrier for generic producers